Search
for
Sort by
Research 151–180 of 1000+
- An excellent response to tofacitinib in a Brazilian adolescent patient with alopecia areata: A case report and a review of the literature
- Evolution of Ritlecitinib Population Pharmacokinetic Models During Clinical Drug Development
- Hair Follicle Reconstruction and Stem Cells
- 075 Clinical investigation of JAK inhibitor Tofacitinib in scarring alopecias
- Case Report: Vitiligo and Alopecia Universalis Following Rituximab Therapy in a Patient with Myasthenia Gravis
- Tangled Causes, Targeted Solutions: A Comprehensive Review of Alopecia.
- Alopecia areata: from immunopathogenesis to emerging therapeutic approaches
- Dermatologic Comorbidities Associated with Atopic Dermatitis Towards a Shared Therapeutical Approach: A Narrative Review
- Nouvelles thérapeutiques dans la prise en charge de l’alopécie androgénétique
- Modern Management Approaches for Alopecia Areata
- Learning from nudity: lessons from the nude phenotype
- 801 TEC family kinase inhibitors as a novel class of therapeutics in alopecia areata
- Alopecia Areata: Burden of Disease, Approach to Treatment, and Current Unmet Needs
- Real-world evidence in alopecia areata treatment: A narrative review
- JAK Inhibitors for Treatment of Alopecia Areata
- A case of atopic dermatitis with alopecia universalis in a patient treated with abrocitinib
- Real‐world experience and long‐term evaluation of tofacitinib in refractory alopecia areata: A prospective, open‐label, single‐center study in Asian Arab population
- Personalized Medicine in the Field of Inflammatory Skin Disorders
- Case Report: Baricitinib improved alopecia areata in a pediatric patient with atopic dermatitis
- Review of efficacy of baricitinib in the treatment of alopecia areata
- JAK 1-3 inhibitors and TYK-2 inhibitors in dermatology: Practical pearls for the primary care physician
- Precision Dermatology: A Review of Molecular Biomarkers and Personalized Therapies
- Pathomechanisms of immune-mediated alopecia
- Efficacy and Safety of Baricitinib in Patients with Severe Alopecia Areata over 52 Weeks of Continuous Therapy in Two Phase III Trials (BRAVE-AA1 and BRAVE-AA2)
- Upadacitinib for Successful Treatment of Alopecia Universalis in a Child: A Case Report and Literature Review
- What is behind the ‘swarm of bees’ in alopecia areata
- What’s New in Hair Loss
- Hair regrowth in a patient with central centrifugal cicatricial alopecia after a 2-month trial of baricitinib
- Alopecia – New building blocks
- Baricitinib: A Review in Severe Alopecia Areata